New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27

New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27

Type 1 diabetes (T1D) is a pancreatic beta cell specific autoimmune disease. One of the most significant current discussions in T1D studies is therapy. Since the conventional therapy, islet transplantation and external insulin, e.g., cannot prevent the destructive autoimmune process against original...

Full description

Bibliographic Details
Main Authors: Fatemeh Zamani, Shohreh Almasi, Tohid Kazemi, Rana Jahanban Esfahlan, Mohammad Reza Aliparasti
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2015-12-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
Type 1 diabetes
Immunotherapy
Cytokine antibody-based drugs
Online Access:http://journals.tbzmed.ac.ir/APB/Manuscript/APB-5-599.pdf

Similar Items

Similar Items